Untreated Dyslipidemia in Lebanese Patients With Schizophrenia.
Conclusions: Although our results showed the superiority of the 2013 ACC/AHA guidelines over the 2004 NCEP guidelines for detecting undiagnosed dyslipidemia, the absolute benefit or risk of a statin therapy according to these guideline recommendations remains unclear in this population of schizophrenic patients because the actual occurrence of CVD or statin-related adverse events was not investigated in this study. Further studies are needed to evaluate the reduction in CVD by a statin treatment according to both guidelines and thus compare the actual benefit of statin assignment in schizophrenic patients.
PMID: 28534599 [PubMed - in process]
Source: The Primary Care Companion for CNS Disorders - Category: Primary Care Tags: Prim Care Companion CNS Disord Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Education | Endocrinology | Heart | Lebanon Health | Primary Care | Psychiatry | Schizophrenia | Statin Therapy | Study | Universities & Medical Training